Clinical trial
The Clinical Carbetocin Myocardium Trial Part 2
NCT03899961 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Clinical Carbetocin Myocardium Trial Part 2
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 2, 2019
- Completion date
- April 15, 2022
- Enrollment
- 240 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.